McKinley Carter Wealth Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-400
Closed -$110K 184
2018
Q1
$110K Buy
+400
New +$124K 0.04% 210

Other funds holding BIIB

McKinley Carter Wealth Services's BIIB Position: Q2 2018 in Review

McKinley Carter Wealth Services sold out of Biogen (BIIB) in Q2 2018, closing a stake of 400 shares — an estimated $110K sold.

McKinley Carter Wealth Services first reported a position in BIIB in Q1 2018 and held it in 1 quarter. The position peaked at $110K in Q1 2018. 1,097 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • McKinley Carter Wealth Services reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • McKinley Carter Wealth Services sold 400 Biogen shares in Q2 2018, an estimated $110K.
  • McKinley Carter Wealth Services first reported a position in Biogen in Q1 2018 and held it in 1 quarter.
  • McKinley Carter Wealth Services's Biogen position peaked at $110K in Q1 2018.
  • 1,097 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on McKinley Carter Wealth Services's 13F filing for Q2 2018, filed 7 Dec 2018.